Therapeutic effects of creatine supplementation in patients with type II diabetes

Background: Type 2 diabetes mellitus (T2DM) prevalence is disturbingly increasing all over the world. Clinicians and patients need new ways of improving T2DM therapy. Aim of this study: The aim of this study is to present the current scientific literature on the potential hypoglycemic effects of cre...

Full description

Saved in:
Bibliographic Details
Main Authors: Aleksander Oskroba (Author), Mateusz Pawlina (Author), Aleksandra Orzechowska (Author), Karolina Ziętara (Author), Natalia Pawełczak (Author), Karolina Raksa (Author), Bartłomiej Zielonka (Author), Ilona Kowalczyk (Author), Piotr Pawłowski (Author), Cezary Stawikowski (Author)
Format: Book
Published: Kazimierz Wielki University, 2023-03-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background: Type 2 diabetes mellitus (T2DM) prevalence is disturbingly increasing all over the world. Clinicians and patients need new ways of improving T2DM therapy. Aim of this study: The aim of this study is to present the current scientific literature on the potential hypoglycemic effects of creatine in patients with type 2 diabetes. Material and methods: A systematic review of the scientific and medical literature from the PubMed and Google Scholar databases was carried out. This was achieved according to the keywords: type 2 diabetes and creatine supplementation. 25 items of literature were qualified for analysis. Results and conclusions: Creatine supplementation, when combined with physical activity, improves glycemic control in type 2 diabetic patients. Increased glucose transfer into muscle cells by type 4 glucose transporter (GLUT-4) translocation to the sarcolemma is one of the potential mechanisms explaining these hypoglycemic effects. Creatine has a big potential to become a nutritional therapy adjuvant for type 2 diabetes. However, in order to draw firm conclusions about the efficacy and safety of creatine as a diabetic intervention, larger, longer-term, controlled trials involving type 2 diabetes with variable disease severity and different pharmacological treatments are required.
Item Description:10.12775/JEHS.2023.16.01.008
2391-8306